Initial Therapeutics
New York, US · Founded 2020
Find your way into Initial Therapeutics
Sign up to find every way you can get introduced to Initial Therapeutics
- Your email: who you already know at Initial Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Initial Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
Initial Therapeutics was founded in 2020 by James H. Doudna Cate.
JH
James H. Doudna CateFounder
Board
SH
Seth HarrisonBoard directorFounder and Managing Partner at Apple Tree Venture Management Llc
Funding
SEC filings, press & company announcements$3.8M disclosed across 1 of 2 rounds · 2020–2023
- Undisclosed amountSeries AMay 2023Source ↗
▶$3.8MraisedFeb 2021 · 1 investors · BiotechnologyRule 506(b)
▶$3.8MraisedFeb 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Seth HarrisonDirector
- Michael EhlersDirector
- James H. Doudna CateDirector
- Rajesh ChopraDirector
- Spiros LirasExecutive Officer, Director
- Offering amount
- $75M
- Amount sold
- $3.8M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Initial Therapeutics?
- Initial Therapeutics was founded by James H. Doudna Cate in 2020.
- How much funding has Initial Therapeutics raised?
- Initial Therapeutics has disclosed $3.8M raised across 1 of its 2 known rounds.
- Where is Initial Therapeutics headquartered?
- Initial Therapeutics is headquartered in New York, US.
